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Utility of Tissue Doppler Imaging in the Echocardiographic
Evaluation of Left and Right Ventricular Function in Dogs with
Myxomatous Mitral Valve Disease with or without Pulmonary
Hypertension
M. Baron Toaldo, H. Poser, G. Menciotti, S. Battaia, B. Contiero, M. Cipone, A. Diana, E. Mazzotta,
and C. Guglielmini
Background: In human medicine, right ventricular (RV) functional parameters represent a tool for risk stratiﬁcation in
patients with congestive heart failure caused by left heart disease. Little is known about RV alterations in dogs with left-sided
cardiac disorders.
Objectives: To assess RV and left ventricular (LV) function in dogs with myxomatous mitral valve disease (MMVD) with
or without pulmonary hypertension (PH).
Animals: One-hundred and fourteen dogs: 28 healthy controls and 86 dogs with MMVD at diﬀerent stages.
Methods: Prospective observational study. Animals were classiﬁed as healthy or having MMVD at diﬀerent stages of
severity and according to presence or absence of PH. Twenty-eight morphological, echo-Doppler, and tissue Doppler imaging
(TDI) variables were measured and comparison among groups and correlations between LV and RV parameters were stud-
ied.
Results: No diﬀerences were found among groups regarding RV echo-Doppler and TDI variables. Sixteen signiﬁcant cor-
relations were found between RV TDI and left heart echocardiographic variables. Dogs with PH had signiﬁcantly higher
transmitral E wave peak velocity and higher E/eʹ ratio of septal (sMV) and lateral (pMV) mitral annulus. These 2 variables
were found to predict presence of PH with a sensitivity of 84 and 72%, and a speciﬁcity of 71 and 80% at cut-oﬀ values of
10 and 9.33 for sMV E/eʹ and pMV E/eʹ, respectively.
Conclusions and clinical importance: No association between variables of RV function and diﬀerent MMVD stage and
severity of PH could be detected. Some relationships were found between echocardiographic variables of right and left ven-
tricular function.
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Abbreviations:
2D 2-dimensional
aʹ late diastolic mitral/tricuspid annular motion
Ao aortic root
BW body weight
CHF congestive heart failure
CV coeﬃcient of variation
CW continuous wave
eʹ early diastolic mitral/tricuspid annular motion
FS fractional shortening
LA/Ao left atrium to aorta diameter
LA left atrium
LV left ventricle
MMVD myxomatous mitral valve disease
PASP pulmonary artery systolic pressure
PH pulmonary hypertension
pMV lateral/parietal mitral valve annulus
RA right atrium
ROC receiver operating characteristic
RV right ventricle
Sa systolic mitral/tricuspid annular motion
SD standard deviation
sMV medial/septal mitral valve annulus
TAPSE tricuspid annular plane systolic excursion
TDI tissue Doppler imaging
TR tricuspid regurgitation
TV tricuspid valve
VI ventricular interdependence
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Myxomatous mitral valve disease (MMVD) is themost common acquired cardiac disease in dogs.
Typically it is associated with left ventricular (LV)
remodeling, left atrial (LA) dilatation, and eventually
congestive heart failure (CHF).1,2 In dogs with left-sided
cardiac disease, the increased LA pressure may lead to
reactive pulmonary arterial vasoconstriction and ﬁnally
pulmonary hypertension (PH), speciﬁcally type 2 PH.3 In
the most severe cases, right ventricular (RV) failure can
be the ultimate sequela to PH.4 Some studies have evalu-
ated the prognostic value of echocardiographic parame-
ters in dogs with preclinical and overt MMVD, mainly
focusing on the assessment of the LV and LA.5,6 In other
studies conducted in dogs with MMVD, PH was evalu-
ated as an indicator of the progression of left-sided heart
failure,7–9 whereas a recent study evaluated RV function
in dogs with PH of diﬀerent origins, regardless of under-
lying left-sided heart disease.10 Therefore, only a few
studies have investigated RV functional and morphologi-
cal alterations in dogs with predominantly left-sided
heart disease, and none of these studies tried to correlate
RV and LV dysfunction.11
In humans, some echocardiographically derived
indices of RV function have proved to be strong inde-
pendent predictors of outcome and adverse events in
patients with CHF caused by left heart disease.12–14
This close relationship between RV and LV function
might be explained by the so called ventricular interde-
pendence (VI) phenomenon. Ventricular interdepen-
dence is deﬁned as the forces that are transmitted from
1 ventricle to the other through the myocardium and
pericardium, independently from neural, humoral, or
circulatory eﬀects.15 This phenomenon occurs both in
diastole and systole and is the consequence of the close
anatomic association between the 2 ventricles. Diastolic
VI is more closely related to the displacement of the
interventricular septum during volume overload of 1
ventricle and by pericardial constriction, whereas sys-
tolic VI mainly is related to the myocardial contractil-
ity, particularly that of the interventricular septum.15,16
The ﬁrst aim of our study was to investigate LV and
RV systolic and diastolic function in dogs with MMVD
at diﬀerent stages and to evaluate noninvasively whether
a correlation between LV and RV echocardiographic
parameters is present in these dogs. A second part of the
study was focused on assessing which of the echocardio-
graphic variables related to the left-sided heart function
are better predictors of the presence of PH.
Materials and Methods
Animals
Dogs were evaluated at the cardiology units of the Veterinary
Teaching Hospitals of the Universities of Bologna and Padova for
cardiac murmurs, clinical signs attributable to heart disease, breed
screening, or pre-anesthetic assessment. Dogs were prospectively
recruited from January 2010 to January 2012 and included in the
study if they had clinical and echocardiographic signs typical for
MMVD and body weight (BW) <21 kg. Dogs with cardiac dis-
eases other than MMVD, or noncardiac systemic comorbidities
evidenced by clinical examination or hematological and biochemi-
cal analyses were not included. Dogs were allowed to receive medi-
cations for CHF if deemed necessary. Healthy dogs were recruited
from students, University staﬀ, and private owners and used as
control group. Dogs were considered clinically healthy on the basis
of cardiovascular examination and complete transthoracic echocar-
diographic and echo-Doppler examination. Reference ranges for
echocardiographic measurements were derived from the veterinary
literature.17
Procedures
All dogs underwent complete clinical examination and cardiac
auscultation. Complete transthoracic echocardiography was per-
formed according to standard techniques18 by 2 investigators
(MBT and HP) using dedicated ultrasound unitsa,b and continuous
ECG tracing. The diagnosis of MMVD was made on the basis of
clinical examination and echocardiographic criteria including
thickening, prolapse or both of the mitral valve leaﬂets on 2-
dimensional (2D) echocardiography and mitral valve insuﬃciency
on color Doppler examination.19 Left ventricular wall thicknesses
and chamber diameters were obtained from 2D-guided M-mode
images acquired from a right parasternal short axis view at the
level of the papillary muscles. These linear measurements (LV wall
thicknesses and diameter) were compared to weight-based refer-
ence values calculated as described elsewhere.17 Left atrial and
aortic root (Ao) diameter were measured on 2D images obtained
from a right parasternal short axis view at the level of aortic root
as previously described, and a left atrial-to-aortic diameter (LA/
Ao) <1.6 was considered normal.20 Left and right ventricular dias-
tolic inﬂows were recorded from the left apical 4-chamber view.
The sample volume of the pulsed wave Doppler was kept
unchanged (2 mm width) and placed just below the atrioventricu-
lar valves in the ventricular cavity. Spectral tissue Doppler imaging
(TDI) was performed at the level of the medial (sMV) and lateral
(pMV) mitral annulus from a left apical 4-chamber view, whereas
tricuspid annular velocity was measured only at the level of the
RV free wall, after optimizing the alignment of the ultrasound
beam with the myocardium as previously described.7,21,22 Three
diﬀerent waves (systolic [Sa], early diastolic [eʹ], and late diastolic
[aʹ]) were recognized and their peak velocities were recorded.23 Tri-
cuspid regurgitation (TR) was evaluated from the right parasternal
short axis view at the basilar level, optimized left apical view or
both, and the highest regurgitant jet velocity, measured using
continuous wave (CW)-Doppler, was chosen.4,24,25 A velocity
>2.8 m/s in the absence of pulmonic stenosis was considered
indicative of PH.3 The modiﬁed Bernoulli equation then was
applied to calculate the right ventricle-to-right atrium (RV-to-RA)
systolic pressure gradient across the tricuspid valve; no estimated
pressure of the right atrium was added to obtain the pulmonary
artery systolic pressure (PASP).8 Presence of pulmonic stenosis
was excluded on the basis of morphologically normal pulmonic
valve and annulus and a peak systolic transpulmonary blood ﬂow
velocity <2.25 m/s.26 Measurements derived from 3 consecutive
beats were averaged for each variable. The list of the variables
used for the study is shown in Table 1. Thoracic radiography was
performed in each dog with MMVD and echocardiographic evi-
dence of LA dilatation to assess the presence of CHF. Only dogs
in sinus rhythm were included in the study.
According to the modiﬁed guidelines for the diagnosis and
treatment of MMVD,2 dogs were divided into diﬀerent groups as
follows: control, healthy dogs (group H); dogs having MMVD
without left heart enlargement (group B1); dogs having MMVD
with LV enlargement, LA enlargement or both but without clinical
and radiographic evidence of CHF (group B2); dogs with symp-
tomatic MMVD and radiographic evidence of pulmonary edema,
pleural eﬀusion or both or dogs with at least 1 conﬁrmed episode
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of CHF in the past (classes C + D, named group S). From the
MMVD population, only dogs having TR jet measurable using
CW-Doppler, were sub-classiﬁed as group 0 (no PH) and group 1
(presence of PH).
Statistical analysis
Descriptive statistics were used for age, sex, and BW. Residual
plots of all dependent variables were inspected to test the appro-
priateness of the linear model hypotheses. Preliminary analyses on
factors and covariates to be included as predictors in the following
ANCOVA model were assessed. To evaluate group eﬀect (H, B1,
B2, and S), a 1-way ANOVA was performed on the continuous
variables (BW and age) and a chi-square test was performed on
the percentage ratio between categorical data (sex, breed). Normal
distribution of the echocardiographic, echo-Doppler, and TDI
variables was assessed using a Shapiro–Wilk test. An ANCOVA
model was used to test the ﬁxed eﬀects of sex, breed (mixed breed
vs pure breed), group of dogs, center of investigation, as well as
the continuous variables BW and age on the echocardiographic,
echo-Doppler, and TDI parameters. The same model was applied
to test the eﬀect of the presence (group 1) or absence (group 0) of
PH on these parameters in dogs with MMVD and measurable
TR.
A posthoc t-test with Bonferroni correction was applied. The
correlation between RV-TDI variables and the other echocardio-
graphic, echo-Doppler, and LV-TDI measurements was tested with
a Pearson correlation index and considered signiﬁcant for
P < .001 and r > 0.3.27 Data are reported as means  standard
deviation (SD).
Tissue doppler imaging variables with a signiﬁcant diﬀerence
between dogs with MMVD with (group 1) and without PH (group 0)
Table 1. Morphological, echo-Doppler, and PW-TDI variables obtained from the left and right ventricle in a
population of 28 healthy dogs and 86 dogs with myxomatous mitral valve disease (MMVD) at diﬀerent stages.
Variable H (n = 28) B1 (n = 36) B2 (n = 28) S (n = 22)
Overall
P Value
Conventional
LA (cm) 2.1  0.53 2.2  0.49 2.7  0.64**,§§ 3.0  0.56**,§§,# <.001
Ao (cm) 1.6  0.38 1.6  0.40 1.5  0.36 1.5  0.48 .661
LA/Ao 1.3  0.18 1.4  0.19 1.8  0.17**,§§ 2.2  0.50 **,§§,## <.001
FS (%) 34.3  6.86 40.5  8.52 45.9  5.87** 50.1  5.51**,§§ <.001
PV vel (cm/s) 88.3  14.86 91.3  20.98 85.6  21.14 74.9  20.04 .05
TR vel (cm/s) NA 262.8  50.70 302.6  58.71 349.9  63.07§§ <.001
RV-to-RA (mmHg) NA 28.6  10.06 38.0  13.30 50.5  18.69§§ <.001
MV E vel (cm/s) 73.1  13.95 81.4  19.99 108.9  32.77**,§§ 148.0  28.86**,§§,## <.001
MV A vel (cm/s) 61.1  16.77 70.9  25.30 87.0  16.62** 58.4  12.50**,§ <.001
MV E/A 1.3  0.32 1.2  0.43 1.3  0.08 1.7  0.56**,§§,## <.001
TV E vel (cm/s) 57.8  13.2 50.60  12.97 54.6  15.20 64.1  14.32 .094
TV A vel (cm/s) 46.2  15.21 49.9  2.35 54.9  15.58 58.4  12.50 .024
TV E/A 1.3  0.37 1.2  0.32 1.0  0.32 1.1  0.27 .263
TDI
pMV Sa (cm/s) 10.62  3.05 10.3  2.68 11.3  2.68 11.9  2.13*,§ .005
pMV eʹ (cm/s) 10.3  2.63 9.6  2.31 11.8  1.80*,§ 11.6  2.92**,§§ <.001
pMV aʹ (cm/s) 8.7  2.18 11.0  4.07 11.8  2.05 10.2  3.56 .010
pMV eʹ/aʹ (cm/s) 1.2  0.48 0.9  0.33 0.9  0.19 1.3  0.56§§,# <.001
pMV E/eʹ 7.4  1.83 8.7  2.32 9.9  2.71 13.3  4.19**,§§,# <.001
sMV Sa (cm/s) 9.5  2.26 9.7  2.35 10.8  3.03 11.4  2.64** .002
sMV eʹ (cm/s) 7.3  1.58 8.0  2.38 9.0  2.64 11.0  3.87**,§§ <.001
sMV aʹ (cm/s) 7.6  1.60 8.7  2.81 9.5  1.88 9.4  3.46 .140
sMV eʹ/aʹ 1.0  0.26 1.0  0.41 1.0  0.27 1.2  0.58 .044
sMV E/eʹ 10.4  2.95 10.8  3.23 12.3  3.80 14.7  4.81§ .006
TV Sa (cm/s) 12.7  3.94 15.0  3.94 15.5  5.04 15.3  3.90 .107
TV eʹ (cm/s) 9.5  2.18 11.1  2.47 11.1  2.96 12.5  3.77* .009
TV aʹ (cm/s) 10.8  3.07 13.4  3.45 15.2  3.93* 13.9  4.52 .009
TV eʹ/aʹ 0.9  0.18 0.8  0.23 0.8  0.25 1.0  0.38 .046
TV E/eʹ 6.3  1.57 5.5  1.17 5.2  1.67 5.7  2.94 .368
Data are expressed as mean  SD. In bold values with statistical diﬀerences.
LA, left atrium; Ao, aorta; LA/Ao, left atrium to aorta ratio; FS, fractional shortening; PV vel, pulmonic valve peak systolic velocity;
TR vel, tricuspid regurgitation maximal velocity; RV, right ventricle; RA, right atrium; MV E vel, peak early diastolic mitral valve velocity;
MV A vel, peak late diastolic mitral valve velocity; TV, tricuspid valve; pMV, lateral mitral valve annulus; sMV, septal mitral valve annu-
lus; vel, velocity; Sa, systolic mitral/tricuspid annular motion; eʹ, early diastolic mitral/tricuspid annular motion; aʹ, late diastolic mitral/tri-
cuspid annular motion; TDI, tissue Doppler imaging; H, healthy control group; B1, dogs with MMVD without cardiac enlargement; B2,
dogs with MMVD and cardiac enlargement; S, dogs with MMVD and clinical signs due to congestive heart failure.
*P < .01 compared with group H.
**P ≤ .001 compared with group H.
§P < .01 compared with group B1.
§§P < .001 compared with group B1.
#P < .01 compared with group B2.
##P ≤ .001 compared with group B2.
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were linearly regressed against the Doppler-derived RV-to-RA
systolic pressure gradient. The ability of these TDI variables to
distinguish between dogs with MMVD and PH from those with
MMVD without PH was evaluated by receiver operating charac-
teristic (ROC) curve analysis. In particular, the sensitivity and
speciﬁcity were calculated at various cut-oﬀ points.
All statistical analyses were performed using commercial dedicated
software.c,d An overall value of P < .01 was considered signiﬁcant.
To assess interobserver measurement variability, 6 echocardio-
graphic datasets from the same number of dogs enrolled into the
study were randomly selected. For each study, 2 operators (MBT
and HP) analyzed and measured the TDI variables obtained by
the spectral TDI proﬁles recorded at the level of the sMV, pMV,
and tricuspid valve (TV). The variability then was quantiﬁed for
each variable as the coeﬃcient of variation (CV) by use of the
equation CV = (mean diﬀerence between measurements/mean of
measurements) 9 100, and expressed as a percentage. The degree
of variability was arbitrarily deﬁned as follows: CV < 5%, very
low variability; 5–15%, low variability; 16–25%, moderate vari-
ability; or >25%, high variability.28
Results
General characteristic of the study population
One-hundred and fourteen dogs met the inclusion cri-
teria. Of these dogs, 28 (24%) were clinically healthy
(group H), 36 (32%) had MMVD without cardiac
enlargement (group B1), 28 (25%) had MMVD with
cardiac enlargement (group B2), and 22 (19%) had
symptomatic MMVD (group S). The mean age of dogs
was signiﬁcantly lower in group H (6.1  3.4 years)
compared to group S (12  1.6 years; P < .001). Mean
BW was <21 kg in dogs of groups B1, B2, and S,
whereas it ranged from 3 to 33 kg in dogs of group H.
Male dogs were overrepresented in groups B1, B2, and
S, whereas female dogs were overrepresented in group
H, but these diﬀerences were not signiﬁcant. Mixed
breed dogs were overrepresented, followed by miniature
Poodles, Cocker Spaniels, Cavalier King Charles Spa-
niels, and Yorkshire terriers. However, no signiﬁcant
group eﬀect was detected between mixed breed and
pure breed dogs. Descriptive characteristics of the study
population are summarized in Table 2.
Of the 86 dogs with MMVD, 74 had combined mitral
and tricuspid regurgitation. Of these, 26 (35%) dogs did
not have Doppler-derived evidence of PH (group 0),
and 48 (65%) had PH (group 1). From the 74 dogs
with TR, the TR peak velocity was recorded from the
optimized left apical view and the right parasternal
short axis view at basilar level in 72 and 2 dogs, respec-
tively, according to the sharper Doppler proﬁle with a
higher peak velocity obtained.
All drugs used in dogs of this study that could have
an impact on hemodynamic variables are listed for each
group of dogs in Table 2.
Table 2. Demographic data from 114 dogs used in this study.
Variable H B1 B2 S
Overall
P Value
No. of dogs 28 36 28 22
Age (years) 6.1  3.4 9.6  3.8** 11.1  2.2** 12  1.6** <.001
Body weight (kg) 13.1  7.3 11.1  6.2 9.3  5.8 8.1  4.0 .019
Sex (male/female) 11/17 20/16 16/12 14/8 .335
Breed (No. of dogs) Mixed breed (10) Mixed breed (17) Mixed breed (15) Mixed breed (11) .723
Cocker Spaniel (5) Yorkshire Terrier,
CKCS (3)
Miniature Poodle,
Maltese, Shih-tzu (2)
Miniature Poodle,
Yorkshire Terrier,
Miniature Pinscher (2)
Maltese, AST (2) Miniature Poodle,
Epagneul
Breton, English
setter,
Dachshund (2)
Other breeds (9) Other breeds (12) Other breeds (20) Other breeds (5)
Medications received
(No. of dogs) [mean
dose received]
None ACE-inhibitor (1)
Enalapril
[0.5 mg/kg q12 h]
ACE-inhibitor (8)
Benazepril
[0.32 mg/kg q24 h
Ramipril
[0.16 mg/kg q24 h]
Pimobendan (1)
[0.25 mg/kg q12 h]
Spironolactone (1)
[2 mg/kg q24 h]
Furosemide (4)
[1.1 mg/kg q12 h]
ACE-inhibitor (18)
Enalapril [0.4 mg/kg q12 h]
Benazepril [0.34 mg/kg q24 h]
Ramipril [0.2 mg/kg q24 h]
Pimobendan (14)
[0.24 mg/kg q24 h]
Spironolactone (2)
[2.4 mg/kg q24 h]
Furosemide (18)
[1.9 mg/kg q12 h]
Data are expressed as mean  SD. In bold values with statistical diﬀerences.
H, healthy control group; B1, dogs with myxomatous mitral valve disease (MMVD) without cardiac enlargement; B2, dogs with MMVD
and cardiac enlargement; S, dogs with MMVD and clinical signs due to congestive heart failure; AST, American Staﬀordshire Terrier;
CKCS, Cavalier king Charles spaniel.
**P < .001 compared with group H.
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Echocardiographic variables in all dogs and
correlation analysis between left and right cardiac
chambers variables
All of the variables were normally distributed. Six of
the 13 morphological and echo-Doppler variables were
signiﬁcantly diﬀerent (Table 1) between dogs with
MMVD at diﬀerent stages and healthy dogs. In particu-
lar, a progressive increase in LA dimension, fractional
shortening (FS), E wave velocity, and E/A ratio from
dogs of group H to those of group S was observed
(overall P < .001 for all variables). Moreover, TR veloc-
ity and RV-to-RA systolic pressure gradient were signif-
icantly higher in dogs of group S compared to those of
groups B1 (P < .001). No statistical diﬀerence was
found regarding RV E and A waves, and their ratio,
among the 4 groups of dogs.
Regarding TDI variables, pMV eʹ and sMV eʹ were sig-
niﬁcantly greater in dogs of group S compared to those
of groups H and B1 (overall P < .001). The pMV E/eʹ
was signiﬁcantly diﬀerent between dogs of group S and
those of all the other groups (overall P < .001), whereas
for sMV E/eʹ a signiﬁcant diﬀerence was found between
dogs of group S and those of group B1 (P < .01). More-
over, sMV Sa was higher in dogs of group S compared to
those of group H (P < .01). Among the RV-TDI vari-
ables a signiﬁcant diﬀerence was found for TVeʹ between
the H and S groups (P < .01) and for TVaʹ between the
H and B2 groups (P < .01).
Results of the ANCOVA model indicated a statisti-
cally signiﬁcant eﬀect of investigation center for only 2
of the 28 measured variables (i.e., MV A vel and pMV
Sa). Body weight had a signiﬁcant positive eﬀect for 4
of 28 variables (i.e., LA, Ao, pMV Sa, and sMV Sa)
and signiﬁcant negative eﬀect for 1 variable (i.e., FS).
Age had a signiﬁcant negative eﬀect for 3 of 28 vari-
ables (i.e., PV vel, pMVe0, and pMVe0/a0). Breed signiﬁ-
cantly aﬀected 2 variables (i.e., TVe0 and TVa0) with
higher values in the mixed breed dogs, whereas sex had
no signiﬁcant eﬀect.
The correlation analysis identiﬁed several positive
and negative correlations between the 5 tested RV-TDI
variables and morphological, echo-Doppler, and TDI
variables of the LA and LV. Sixteen signiﬁcant correla-
tions (P < .001) with values of r > 0.3 were found
between RV TDI and left heart echocardiographic
variables (Table 3).
Echocardiographic variables in dogs with MMVD with
or without PH and prediction of PH on the basis of
LV-TDI parameters
Left atrial diameter and MV peak E wave velocity
were signiﬁcantly higher in dogs of group 1 compared
to those of group 0. Regarding TDI parameters, values
of pMV E/eʹ and sMV E/eʹ were higher in dogs of
group 1 compared to those of group 0 (P = .001 and
P < .001, respectively; Table 4). These 2 variables were
signiﬁcantly positively correlated with RV-to-RA sys-
tolic pressure gradient (r = 0.241 and r = 0.339, respec-
tively; Fig. 1). Results of ROC curve analysis to predict
the presence of PH using these 2 variables are shown in
Figure 2 and listed in Table 5. The variable sMV E/eʹ
Table 3. Correlation analysis between RV TDI variables and left heart echocardiographic parameters in a popula-
tion of 114 dogs used in this study.
Variable
TV Sa TV eʹ TV aʹ TV eʹ/aʹ TV E/eʹ
r P r P r P r P r P
Conventional
LA (cm) 0.262 .005 0.365 <.001 0.171 .072 0.157 .098 0.153 .106
Ao (cm) 0.183 .054 0.161 .089 0.055 .565 0.065 .493 0.173 .067
LA/Ao 0.090 .346 0.232 .013 0.127 .181 0.105 .271 0.022 .820
FS (%) 0.186 .050 0.227 .016 0.399 <.001 0.192 .043 0.023 .807
MV E vel (cm/s) 0.243 .010 0.432 <.001 0.320 .001 0.114 .229 0.165 .083
MV A vel (cm/s) 0.196 .038 0.312 .001 0.470 <.001 0.201 .034 0.091 .339
TDI
pMV Sa (cm/s) 0.432 <.001 0.446 <.001 0.275 .005 0.138 .164 0.220 .025
pMV eʹ (cm/s) 0.236 .016 0.274 .005 0.071 .479 0.227 .021 0.006 .951
pMV aʹ (cm/s) 0.382 <.001 0.384 <.001 0.440 <.001 0.121 .221 0.280 .004
pMV eʹ/aʹ (cm/s) 0.165 .095 0.094 .344 0.298 .002 0.255 .009 0.189 .055
pMV E/eʹ 0.071 .477 0.277 .004 0.225 .022 0.028 .777 0.116 .244
sMV Sa (cm/s) 0.541 <.001 0.363 <.001 0.245 .011 0.055 .572 0.087 .374
sMV eʹ (cm/s) 0.315 .001 0.418 <.001 0.065 .508 0.342 <.001 0.143 .147
sMV aʹ (cm/s) 0.327 .001 0.410 <.001 0.511 <.001 0.195 .046 0.249 .011
sMV eʹ/aʹ 0.092 .355 0.089 .369 0.316 .001 0.468 <.001 0.010 .921
sMV E/eʹ 0.003 .980 0.118 .230 0.299 .002 0.170 .082 0.005 .960
In bold variables with signiﬁcant correlation (P < .001 and r > 0.3).
RV, right ventricle; TDI, tissue Doppler imaging; LA, left atrium; Ao, aorta; LA/Ao, left atrium to aorta ratio; FS, fractional shorten-
ing; MV E vel, peak early diastolic mitral valve velocity; MV A vel, peak late diastolic mitral valve velocity; pMV, lateral mitral valve
annulus; sMV, septal mitral valve annulus; vel, velocity; Sa, systolic mitral/tricuspid annular motion; eʹ, early diastolic mitral/tricuspid
annular motion; aʹ, late diastolic mitral/tricuspid annular motion; TV, tricuspid valve.
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had the highest accuracy (area under the ROC
curve = 0.820, at the threshold value of 10), whereas a
slightly lower value was found for pMV E/eʹ (area
under the ROC curve = 0.794, at the threshold value of
9.33).
Interobserver measurement variability
Interobserver measurement variability for the 9 TDI
variables tested was always very low or low. The CV
were as follows: <5% for pMV Sa, sMV Sa, sMV aʹ,
and all of the TV TDI variables (TV Sa, TV eʹ, and TV
aʹ) and between 5 and 15% for pMV eʹ, pMV aʹ, and
sMV eʹ.
Discussion
We evaluated diﬀerent echocardiographic systolic and
diastolic parameters from both ventricles in dogs with
MMVD at diﬀerent stages of disease, with or without
PH. The major ﬁndings include: the absence of statisti-
cal diﬀerence among MMVD classes and PH groups
regarding RV systo-diastolic function; the linear corre-
lation between the analyzed echocardiographic parame-
ters of LV and RV function; the direct correlation
between some diastolic parameters of the LV (speciﬁ-
cally the MV E/eʹ ratio), and the calculated RV-to-RA
systolic pressure gradient.
Regarding the morphological variables of the left
heart, our results are similar to those previously
reported.5,6 The degree of LA dilatation increased with
progression of the disease as expected because of the
progression of MMVD and myocardial remodeling.5,6
Regarding MV annulus TDI parameters, our ﬁndings
are similar to previous observations reported in a simi-
lar cohort of dogs.29 In particular, a progressive
increase in MV eʹ peak velocity with the progression of
disease and an increase in MV eʹ/aʹ ratio were found in
the dogs of our study. The change in these diastolic
parameters can be a consequence of the hyperkinetic
LV that occurs secondary to mitral regurgitation, with
subsequent enhanced relaxation properties and improve-
ment in overall diastolic ventricular function.30
Pulmonary hypertension might aﬀect RV perfor-
mance by increasing wall stress and decreasing systolic
function.7,10 However, no statistical diﬀerence was
found among groups regarding RV echo-Doppler and
TDI parameters. Decreased tricuspid annular Sa wave
velocity and decreased e0/a0 ratio have been reported
previously.7 This discrepancy can be explained by the
diﬀerent technique employed to measure cardiac tissue
velocity,21 color-coded TDI and PW-TDI in the previ-
ous study and our study, respectively. Right ventricular
systolic dysfunction has been identiﬁed in dogs with PH
of diﬀerent origin by measuring the tricuspid annular
plane systolic excursion (TAPSE).10 This parameter of
longitudinal RV contractility has been found to corre-
late with RV ejection fraction and to predict survival
with good accuracy in human patients with PH.31,32
Conversely, no signiﬁcant correlation between TAPSE
and PH severity was found in dogs with MMVD,33 but
neither TAPSE nor other echocardiographic indicators
of RV systolic function (e.g., the isovolumic contraction
time at TDI of the TV)31 were measured in dogs of our
study. In humans with advanced left heart failure
caused by ischemic myocardial disease, dilated car-
diomyopathy, or valvular regurgitation, RV dysfunction
usually is present and represents an important prognos-
tic criterion to stratify patients.12,13,34,35 The severely
decreased LV systolic function found in human patients
with left-sided cardiac disorders likely is responsible for
the decreased contractile properties of the interventricu-
lar septum, which directly aﬀect the RV function and
lead to biventricular failure.15,16 Results of our study
suggest the absence of signiﬁcant right heart dysfunc-
tion even in the advanced stages of MMVD in dogs. A
Table 4. Morphological, echo-Doppler, and TDI vari-
ables obtained from the left and right ventricle in a
population of 74 dogs with myxomatous mitral valve
disease without (group 0) and with (group 1)
pulmonary hypertension.
Variable
Group 0
(n = 26)
Group 1
(n = 48)
Overall
P Value
Conventional
LA (cm) 2.5  0.67 2.7  0.63 .007
Ao (cm) 1.6  0.34 1.5  0.39 .461
LA/Ao 1.5  0.39 1.9  0.49 .034
FS (%) 40.6  8.23 46.7  7.37 .067
PV vel (cm/s) 89.3  23.72 79.4  19.58 .221
TR vel (cm/s) 235.6  43.32 334.6  47.98 <.001
RV-to-RA (mmHg) 22.9  7.24 45.7  14.09 <.001
MV E vel (cm/s) 82.3  24.42 124.2  38.21 <.001
MV A vel (cm/s) 68.3  22.55 86.7  23.57 .010
MV E/A 1.2  0.29 1.5  0.56 .028
TV E vel (cm/s) 57.3  16.44 57.8  13.34 .916
TV A vel (cm/s) 48.6  16.53 56.9  12.35 .108
TV E/A 1.2  0.35 1.0  0.29 .097
TDI
pMV Sa (cm/s) 10.7  2.67 11.3  2.61 .157
pMV eʹ (cm/s) 10.4  2.67 10.8  2.36 .429
pMV aʹ (cm/s) 11.2  4.04 11.1  3.32 .641
pMV eʹ/aʹ (cm/s) 1.0  0.28 1.1  0.47 .574
pMV E/eʹ 8.2  1.82 11.6  3.83 .001
sMV Sa (cm/s) 10.7  3.32 10.6  2.44 .446
sMV eʹ (cm/s) 9.2  3.41 9.4  3.08 .590
sMV aʹ (cm/s) 8.5  2.71 9.5  2.83 .182
sMV eʹ/aʹ 1.1  0.39 1.0  0.47 .742
sMV E/eʹ 9.4  2.30 13.6  4.09 <.001
TV Sa (cm/s) 15.6  4.31 15.0  4.58 .837
TV eʹ (cm/s) 11.4  3.16 11.6  3.12 .543
TV aʹ (cm/s) 13.1  3.38 14.6  4.19 .501
TV eʹ/aʹ 0.9  0.28 0.8  0.30 .986
TV E/eʹ 5.4  1.79 5.3  1.95 .495
Data are expressed as mean  SD. In bold values with statisti-
cal diﬀerences.
TDI, tissue Doppler imaging; LA, left atrium; Ao, aorta; FS,
fractional shortening; PV, pulmonic valve; TR, tricuspid regurgita-
tion; RV, right ventricle; RA, right atrium; MV, mitral valve; MV
E vel, peak early diastolic mitral valve velocity; MV A vel, peak
late diastolic mitral valve velocity; TV, tricuspid valve; pMV, lat-
eral mitral valve annulus; sMV, septal mitra valve annulus; vel,
velocity; Sa, systolic mitral/tricuspid annular motion; eʹ, early dias-
tolic mitral/tricuspid annular motion; aʹ, late diastolic mitral/
tricuspid annular motion.
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certain degree of RV abnormality could have been
detected by evaluating other echocardiographic parame-
ters of myocardial function, such as TAPSE, strain, and
strain rate, or using magnetic resonance imaging.
In our study, we found several signiﬁcant but weak
correlations between left and right echocardiographic
functional parameters. In particular, the highest (i.e.,
r > 0.4) positive correlations were observed for the dias-
tolic variables MV E wave peak velocity and TV eʹ
wave peak velocity, MV A wave peak velocity and TV
aʹ wave peak velocity, and MV and TV eʹ and aʹ waves
peak velocity and their ratios (eʹ/aʹ). Moreover, a posi-
tive correlation was found between the systolic parame-
ters of the 2 ventricles expressed by TDI annular peak
Fig 1. Regression analysis between the right ventricle-to-right atrium (RV-to-RA) systolic pressure gradient and the tissue Doppler imag-
ing variables (left panel) ratio between mitral valve peak E wave velocity and mitral annular early diastolic velocity at the level of the lat-
eral wall (pMV E/eʹ), and (right panel) ratio between mitral valve peak E wave velocity and mitral annular early diastolic velocity at the
level of the interventricular septum (sMV E/eʹ).
Fig 2. Receiver operating characteristic (ROC) curves of 2 tissue Doppler imaging parameters to predict presence of pulmonary hyperten-
sion in 74 dogs with myxomatous mitral valve disease and tricuspid regurgitation. (A) The ROC curve of the ratio between mitral valve
peak E wave velocity and mitral annular early diastolic velocity at the level of the lateral wall (pMV E/eʹ). (B) The ROC curve of the ratio
between mitral valve peak E wave velocity and mitral annular early diastolic velocity at the level of the lateral wall (sMV E/eʹ).
Table 5. Sensitivity and speciﬁcity of 2 TDI left ventricular variables to predict presence of pulmonary hypertension
in 79 dogs with MMVD.
Independent Variable Area Under ROC Curves 95% CI Cut-oﬀ Points Se Sp P
sMV E/eʹ 0.820 0.713–0.900 ≥5.6 1.00 0.00 <.001
>10.0 0.84 0.71
>14.7 0.37 1.00
pMV E/eʹ 0.794 0.683–0.880 ≥1.7 1.00 0.00 <.001
>9.3 0.72 0.80
>11.6 0.37 1.00
In bold cut-oﬀ points with the best accuracy in predicting presence of pulmonary hypertension. TDI, tissue Doppler imaging; MMVD,
myxomatous mitral valve disease; sMV, septal mitral valve annulus; pMV, parietal mitral valve annulus; ROC, receiver operating; Se, sen-
sitivity; Sp, speciﬁcity.
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systolic velocities (Sa waves). Whether these correlations
are a consequence of the mechanism of VI or secondary
to the eﬀect of the autonomic nervous system, which
aﬀects similarly both ventricles, could not be completely
assessed. However, a detrimental eﬀect on RV perfor-
mance secondary to left heart failure probably is mini-
mal or not identiﬁable with echocardiography in dogs
with MMVD because clinically relevant systolic dys-
function rarely is observed in these dogs.1
In our study, the TDI parameters pMV E/eʹ and
sMV E/eʹ at the cut-oﬀ values of 9.33 and 10, respec-
tively, were moderately accurate in predicting PH in
dogs with MMVD and TR. Previous studies conducted
in human patients and dogs with experimentally
induced mitral regurgitation showed that MV E/eʹ ratio
strongly correlates with mean LA pressure.29,36,37 How-
ever, this seems not to be true in dogs with naturally
occurring MMVD.38
Our study had some limitations. First, echocardio-
graphic estimation of PASP was not conﬁrmed by car-
diac catheterization and direct measurement of arterial
pressures. In humans, the use of Doppler-derived esti-
mation of PASP may be inaccurate in individual
patients, leading to an underestimation of actual PASP,
whereas overestimation of pulmonary pressure
>10 mmHg is very common.32 Therefore, PH cannot be
reliably deﬁned by a cut-oﬀ value of Doppler-derived
pulmonary artery systolic pressure. Consequently, esti-
mation of PASP based on Doppler transthoracic
echocardiography measurement is not suitable for
screening for mild, asymptomatic PH in people.32
Recently, echocardiographic and invasive estimation of
PASP were compared in a canine model of acutely
induced PH.24 Despite a signiﬁcant correlation between
noninvasive estimates and invasive measurements of
PASP, the relationship between the 2 subsets of values
was highly variable.24 The cut-oﬀ value of 2.8 m/s for
TR peak systolic velocity has been arbitrarily proposed
in veterinary medicine to diagnose PH in dogs,
although it is not always accurate in predicting an
actual increase in PASP.3,4,24 Misdiagnosis of PH in
some dogs of our study could not be completely
excluded and may have led to an underpowered correla-
tion analysis. Moreover, the peak velocity of TR was
recorded from the right parasternal short axis view at
basilar level instead of from the optimized left apical
view in 2 of 74 dogs because of higher TR peak velocity
recorded from the former compared to the latter view.
This approach was considered best to avoid underesti-
mation of the RV-to-RA systolic pressure gradient
because Doppler can underestimate but not overesti-
mate blood ﬂow velocity. Second, the echocardio-
graphic parameters we used to assess RV performance
may not have been sensitive enough to detect mild sys-
tolic dysfunction. Tricuspid annular plane systolic
excursion is known to be a better indicator of decreased
contractility of the RV in humans.32 However, because
TAPSE is a dimensional parameter that varies among
dogs according to BW, it is less suitable for a statistical
comparison of a heterogeneous population of dogs of
diﬀerent breeds and body sizes.10 Another factor that
might have inﬂuenced our results is the eﬀect of the
drugs used for heart failure treatment on PH and ven-
tricular function. The dogs enrolled in the study were
treated following proposed guidelines for the manage-
ment of MMVD.2 A higher number of dogs in group 1
compared to those of group 0 received pimobendan and
furosemide, because dogs in more advanced classes of
heart disease are more prone to develop PH.27
Pimobendan can induce pulmonary arterial vasodilata-
tion,39 but its eﬀectiveness in decreasing PASP in dogs
with MMVD is only mild.40
Some diﬀerences in the demographic characteristics
of the 4 groups (H, B1, B2, and S) might also have
inﬂuenced our results. In particular, BW, age, and breed
aﬀected only 4, 3 and 2 of 28 echocardiographic param-
eters we investigated, respectively. Therefore, the com-
parison of some variables (i.e., LA, Ao, pMV Sa, sMV
Sa, and FS) between group H and S should be consid-
ered with caution. Finally, dogs described in this study
were enrolled at 2 diﬀerent centers and were examined
by 2 operators using diﬀerent ultrasound units. An
independent echocardiographic evaluation of a subset
of dogs by each observer was not feasible. However,
standardized echocardiographic scan planes were
employed in each center and the ANCOVA analysis
indicated a very limited center eﬀect on the measured
echocardiographic variables.
In conclusion, we were not able to identify a signiﬁ-
cant deterioration of RV systolic or diastolic function
with the progression of severity class in dogs with natu-
rally occurring MMVD and diﬀerent degrees of PH.
Transthoracic echocardiography appeared useful to rec-
ognize some relationships between functional variables
of the RV and LV at diﬀerent stages of disease.
Footnotes
a iU22 ultrasound system, Philips Healthcare, Monza, Italy
b Zone Ultra, Zonare, Mountain View, CA
c SAS version 9.3, SAS Institute Inc., Cary, NC
d MedCalc version 12.6.1.0, MedCalc Software, Ostend, Belgium
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